Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | VRTX | REGN | GSK |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 149.59 | 314.70 | 442.54 | 993.00 | 44.53 |
| High | 152.05 | 315.00 | 449.91 | 997.87 | 45.80 |
| Low | 149.59 | 308.52 | 441.40 | 981.57 | 44.42 |
| Last | 150.90 | 309.41 | 447.53 | 983.80 | 45.78 |
| Change | +1.28 | -5.44 | +5.53 | -10.15 | +1.32 |
| % Change | +0.86% | -1.73% | +1.25% | -1.02% | +2.97% |
| Volume | 350,700 | 2,849,100 | 1,084,600 | 308,600 | 6,830,700 |
| 20-Day Average Volume | 485,895 | 2,852,140 | 1,105,530 | 450,405 | 3,869,725 |
| Previous Close | 149.62 | 314.85 | 442.00 | 993.95 | 44.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 149.36 | 299.59 | 418.91 | 951.82 | 43.86 |
| 20-Day Raw Stochastic | 66.04% | 76.81% | 95.91% | 88.53% | 97.17% |
| 20-Day Relative Strength | 50.80% | 60.43% | 70.83% | 59.95% | 67.71% |
| Weighted Alpha | -20.94 | +39.19 | +36.83 | +34.82 | +37.95 |
| Today's Opinion | 48% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 72% Buy | 72% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 40% Sell | 24% Buy | 24% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.37% since 05/15/24 | -3.02% since 05/15/24 | +2.29% since 05/15/24 | +0.57% since 05/15/24 | +0.18% since 05/15/24 |
| Low | 144.73 on 05/16/24 | 308.52 on 05/22/24 | 432.22 on 05/16/24 | 966.00 on 05/17/24 | 44.40 on 05/20/24 |
| High | 152.05 on 05/22/24 | 316.67 on 05/21/24 | 449.91 on 05/22/24 | 997.87 on 05/22/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | +3.51% since 04/22/24 | +13.79% since 04/22/24 | +11.90% since 04/22/24 | +9.29% since 04/22/24 | +12.79% since 04/22/24 |
| Low | 141.98 on 04/25/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 40.60 on 04/23/24 |
| High | 155.49 on 05/08/24 | 322.60 on 05/03/24 | 449.91 on 05/22/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -7.32% since 02/22/24 | +8.50% since 02/22/24 | +4.86% since 02/22/24 | +1.96% since 02/22/24 | +8.59% since 02/22/24 |
| Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 163.01 on 02/23/24 | 322.60 on 05/03/24 | 449.91 on 05/22/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -7.36% since 11/22/23 | +16.94% since 11/22/23 | +26.70% since 11/22/23 | +23.02% since 11/22/23 | +30.06% since 11/22/23 |
| Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.35 on 11/29/23 |
| High | 199.38 on 01/09/24 | 329.72 on 02/05/24 | 449.91 on 05/22/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,925,732 | 168,896,560 | 114,059,432 | 109,519,368 | 92,140,680 |
| Shares Outstanding, K | 126,492 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 494,330,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -65,940,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.41 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 05/02/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.88 | 29.61 | 26.60 | 11.04 |